MARTA
HERREROS VILLANUEVA
Forscherin bis um 2022
Complejo Asistencial Universitario de Burgos
Burgos, EspañaPublikationen in Zusammenarbeit mit Forschern von Complejo Asistencial Universitario de Burgos (13)
2020
-
Validation of miR-1228-3p as housekeeping for microRNA analysis in liquid biopsies from colorectal cancer patients
Biomolecules, Vol. 10, Núm. 1
2019
-
Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer
Clinical and translational gastroenterology, Vol. 10, Núm. 1, pp. e00003
2018
-
Plasma miRNAs signature validation for early detection of colorectal cancer
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. v106
2015
-
Pharmacogenomic biomarkers for colorectal cancer treatment
Cancer Treatment Communications
2013
2012
-
Changes in the levels of thioredoxin and indoleamine-2,3-dioxygenase activity in plasma of patients with colorectal cancer treated with chemotherapy
Biochemistry and Cell Biology, Vol. 90, Núm. 2, pp. 173-178
-
KRAS assay selection: Sensitivity and accuracy in clinical application
Molecular Biology Reports, Vol. 39, Núm. 3, pp. 2467-2470
-
No evidence for PML-RARa bcr1 fusion gene in colorectal cancer
Molecular Biology Reports, Vol. 39, Núm. 5, pp. 5387-5391
2011
-
KRAS, BRAF, EGFR and HER2 gene status in a Spanish population of colorectal cancer
Molecular Biology Reports, Vol. 38, Núm. 2, pp. 1315-1320
-
PIK3CA mutations in KRAS and BRAF wild type colorectal cancer patients. A study of Spanish population
Molecular Biology Reports, Vol. 38, Núm. 2, pp. 1347-1351
2010
-
Estrés oxidativo en el infarto cerebral
Revista Electrónica de Biomedicina, Núm. 3, pp. 21-26
-
No evidence for JAK2 V617F mutation in colorectal cancer
British Journal of Biomedical Science, Vol. 67, Núm. 4, pp. 220-222
-
TAp73 is one of the genes responsible for the lack of response to chemotherapy depending on B-Raf mutational status
Journal of Translational Medicine, Vol. 8